Presented By: Olga Weinberg, MD Professor of Pathology, UT Southwestern Medical Center
Hematological malignancies are a heterogeneous group of diseases with diverse presentations and incidence.Major advances in molecular and cell biology have improved our understanding of the pathophysiology of myeloid neoplasms, expanded treatment options, and provided a deeper understanding of how and why individual patients may be at increased risk for development of hematologic malignancies. The recent accumulation of genetic data on the molecular underpinnings of myeloid neoplasms as well as numerous recently approved novel therapies have highlighted areas of controversy in how we currently define and classify myeloid malignancies. Pathologic examination of bone marrow is the definitive diagnostic procedure for hematopoietic disorders, both benign and malignant. For many patients, it is the final step in identifying previously elusive disorders. This talk will focus on presentation and areas of diagnostic confusion among myeloid malignancies.
Learning Objectives:
- Provide overview of myeloid malignancies and clinical diagnosis
- Cover recent genetic findings in myeloid neoplasms with phenotypic correlations
- Discuss controversial areas in myeloid neoplasms diagnosis
All webinars will begin promptly at 11:00 AM Eastern Time US and are approximately 50 minutes long. There is no charge to participate in the live webinar.
All archived webinars are available for free to ISLH Members. You can access the webinars by logging into your ISLH Member account or visiting the ISLH Education webpage.
We look forward to your participation in this event!
REGISTER NOW
